These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10714789)

  • 21. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.
    Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN
    Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It's time to step up the management of community-acquired pneumonia.
    Idemyor V
    J Natl Med Assoc; 2002 Mar; 94(3):178-81. PubMed ID: 11918388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the combination effect of macrolide antibiotics in community-acquired pneumonia.
    Emmet O'Brien M; Restrepo MI; Martin-Loeches I
    Respir Investig; 2015 Sep; 53(5):201-9. PubMed ID: 26344609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 29. Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?
    Bauer T; Ewig S; Marcos MA; Schultze-Werninghaus G; Torres A
    Med Clin North Am; 2001 Nov; 85(6):1367-79. PubMed ID: 11680107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
    Bartlett JG
    Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia.
    Campbell GD
    Chest; 1999 Mar; 115(3 Suppl):14S-18S. PubMed ID: 10084454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.
    Mills GD; Oehley MR; Arrol B
    BMJ; 2005 Feb; 330(7489):456. PubMed ID: 15684024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective open-label randomized comparative, non-inferiority study of two initial antibiotic strategies for patients with nursing- and healthcare-associated pneumonia: Guideline-concordant therapy versus empiric therapy.
    Matsuda S; Ogasawara T; Sugimoto S; Kato S; Umezawa H; Yano T; Kasamatsu N
    J Infect Chemother; 2016 Jun; 22(6):400-6. PubMed ID: 27062334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empiric therapy of community-acquired pneumonia.
    Green DS; San Pedro GS
    Semin Respir Infect; 2000 Sep; 15(3):227-33. PubMed ID: 11052423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard case management of pneumonia in hospitalized children in Uruguay, 1997 to 1998.
    Pírez MC; Martínez O; Ferrari AM; Nairac A; Montano A; Rubio I; Saráchaga MJ; Brea S; Picon T; Pinchack MC; Torello P; Algorta G; Mogdasy MC
    Pediatr Infect Dis J; 2001 Mar; 20(3):283-9. PubMed ID: 11303831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the Best Initial Oral Antibiotics for Adults with Community-Acquired Pneumonia: A Network Meta-Analysis.
    Kurotschka PK; Bentivegna M; Hulme C; Ebell MH
    J Gen Intern Med; 2024 May; 39(7):1214-1226. PubMed ID: 38360961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
    Mufson MA; Chan G; Stanek RJ
    Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.